Search results
Results from the WOW.Com Content Network
The RAQoL was developed by Galen Research, the University of Leeds and the Academic Hospital Maastricht, and was first published in 1997. [5] It was the first patient completed quality of life questionnaire that focused on rheumatoid arthritis [6] and is distinct from other questionnaires as it includes physical contact as a dimension of quality of life. [3]
Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. [1] It typically results in warm, swollen, and painful joints. [1] Pain and stiffness often worsen following rest. [1] Most commonly, the wrist and hands are involved, with the same joints typically involved on both sides of the body. [1]
[23] [24] [25] This TNF-blocking biologic agent has proven to be a successful treatment modality for a broad array of chronic inflammatory diseases, including rheumatoid arthritis. In 1998, his clinical research group was involved in the introduction and implementation of the anti-cyclic citrullinated peptides (anti-CCP) test in rheumatology ...
The foundation is engaged in basic and clinical research in Ayurveda, the clinical trial conducted at The Ayurvedic Trust in collaboration with UCLA Medical School on rheumatoid arthritis to see which works better for rheumatoid arthritis, Ayurveda or the Western drug methotrexate [6] was pronounced as a blue print on how clinical research can be done in complementary and alternative medicine ...
NIAMS' mission is to support the research of arthritis, musculoskeletal and skin diseases. The institute also disseminates information on research progress in these diseases. [3] NIAMS supports and conducts basic, clinical, translational and epidemiologic research and research training at universities and medical centers. [4]
Rheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriatic disease, connective tissue diseases, prevention of autoimmune diseases, factors leading to persistent inflammation, Scleroderma, Sjogren Syndrome, immunopathogenesis, immunotherapy, disease prevention, ultrasound, MRI imaging
The Kennedy Trust for Rheumatology Research is a registered UK charity [1] which funds the Kennedy Institute as well as a range of individual UK university-based researchers. Its longer-term objective is to "achieve a meaningful impact in the development of cures and preventative treatment for musculoskeletal and related inflammatory diseases".
Lars Klareskog (born 1945) is a Swedish physician, immunologist, and rheumatologist, known for research into the genetics of autoimmune diseases such as rheumatoid arthritis (RA). Klareskog received his medical degree from the University of Uppsala in 1974 and received his doctorate in 1978 with thesis On the structure, function and tissue ...